Abhinav V Reddy
Overview
Explore the profile of Abhinav V Reddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang M, Liu L, Li X, Jiang W, Xiao J, Hao Q, et al.
J Gastrointest Oncol
. 2024 May;
15(2):730-746.
PMID: 38756638
Background: Solute carrier family 16 member 1 () serves as a biomarker in numerous types of cancer. Tumor immune infiltration has drawn increasing attention in cancer progression and treatment. The...
2.
He Y, Du Z, Peng H, Reddy A, Cao P
J Gastrointest Oncol
. 2024 Mar;
15(1):435-457.
PMID: 38482253
Background: Pancreatic cancer (PC) is an aggressive disease with a very poor prognosis. The insidious onset, rapid progression, and resistance to conventional therapies mark the imperious need for novel biomarkers...
3.
Liu I, Gearhart S, Ke S, Hu C, Chung H, Efron J, et al.
Surg Open Sci
. 2024 Feb;
18:42-49.
PMID: 38318322
Background: Total neoadjuvant therapy (TNT) is an accepted approach for the management of locally advanced rectal cancer (LARC) and is associated with a decreased risk of development of metastatic disease...
4.
Wong S, Reddy A, Hacker-Prietz A, Kress L, Pathak P, Hill C, et al.
Support Care Cancer
. 2023 May;
31(6):322.
PMID: 37148382
Purpose: Proactive nutrition screening and intervention is associated with improved outcomes for patients with pancreatic adenocarcinoma (PDAC). To better optimize nutrition amongst our PDAC population, we implemented systematic malnutrition screening...
5.
Reddy A, Meyer J
Int J Radiat Oncol Biol Phys
. 2023 Jan;
115(2):276.
PMID: 36621227
No abstract available.
6.
Reddy A, Hill C, Zheng L, He J, Narang A
Radiat Oncol
. 2022 Oct;
17(1):173.
PMID: 36307845
Background: Localized pancreatic adenocarcinoma carries a poor prognosis even after aggressive therapy. Up to 40% of patients may develop locoregional disease as the first site of failure. As such, there...
7.
Gong Y, Liu X, Sahu A, Reddy A, Wang H
Ann Transl Med
. 2022 Aug;
10(15):834.
PMID: 36034995
Background: Gastric cancer (GC) is the 5th most common cause of cancer in the world and the 3rd largest cause of cancer-related death. It is usually associated with a variety...
8.
Reddy A, Hill C, Sehgal S, He J, Zheng L, Herman J, et al.
J Gastrointest Oncol
. 2022 Jul;
13(3):1402-1412.
PMID: 35837183
Background: To report on a cohort of radiation-naïve patients with pancreatic cancer who developed isolated local recurrence following surgical resection and were subsequently treated with stereotactic body radiation therapy (SBRT)....
9.
Reddy A, Hill C, Sehgal S, Zheng L, He J, Laheru D, et al.
Radiat Oncol J
. 2022 Jul;
40(2):111-119.
PMID: 35796114
Purpose: To investigate the role of pre- and post-stereotactic body radiation therapy (SBRT) neutrophil-to-lymphocyte ratio (NLR) in patients with localized pancreatic cancer treated with anti-PD-1 (programmed cell death protein-1) antibody...
10.
Reddy A, Safar B, Jia A, Azad N, Christenson E, Atallah C, et al.
Am J Clin Oncol
. 2022 Jun;
45(7):298-305.
PMID: 35700084
Purpose: The purpose of his study was to report on a cohort of patients managed with nonoperative management (NOM) with a watch-and-wait strategy after achieving complete response (CR) to sequential...